Patient information for AMINOPLASMAL 10% SOLUTION FOR INFUSION Including dosage instructions and possible side effects. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION. ml of solution contain. Amino acids: Isoleucine. g. Leucine. g. Glucose 5 g/ ml B. Braun Vet Care solution pour perfusion pour bovins, chevaux, ovins, caprins, porcins, chiens et chats (Belgium). Glucose 5 g/ ml B .

Author: Brarn Meztigis
Country: Slovenia
Language: English (Spanish)
Genre: Technology
Published (Last): 14 June 2005
Pages: 404
PDF File Size: 3.75 Mb
ePub File Size: 9.25 Mb
ISBN: 578-6-61856-375-9
Downloads: 6877
Price: Free* [*Free Regsitration Required]
Uploader: Brami

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content. Always consult your healthcare provider to ensure 110 information displayed on this page applies to your personal circumstances. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.

Available for Android and iOS devices. Subscribe to receive email notifications whenever new articles are published. This a,inoplasmal is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. To view content sources and attributions, please refer to our editorial policy. We comply with the HONcode standard for trustworthy health information – verify aminlplasmal. You may need to read it again. Do not pass it on to others.

Aminoplasmal® – Amino acid solution for parenteral nutrition | German Healthcare Export Group e.V.

aminoplaemal It may harm them, even if their symptoms are the same as yours. Before you use B. How to use B. Possible side effects 5. How to store B.


The solution is called a nutritional supplement. It contains amino acids that are essential for the body to grow or to recover. You will receive this solution if you cannot eat food normally. When you receive this solution aminopplasmal will also receive others like glucose solutions or fat emulsions.


This solution must not be administered to new-born babies and children under 2 years. You should not receive any infusions if you have: Special care will be taken with B. Taking or using other medicines You should inform your doctor or pharmacist if you are amunoplasmal or have recently taken any other medicines, even those not prescribed.

Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. Your doctor will decide very carefully whether or not you should receive this solution in these situations.

Driving or using machines B. This will exclude driving and using machines. In general, this will be 10 — 20 ml per kg of your body weight per day. The solution will run in at a rate of not more than 1 ml per kg of your body weight per hour.


The amounts to be given to children will be approximately: Duration of use B. Method of administration The solution will be administered to you through a small plastic tube inserted into one of your large veins. If you receive more B. aminop,asmal

However, if you receive an overdose or the solution is running in too fast, you will lose part of the amino acids in urine, aminoplasmaal may feel sick or vomit or you may shiver. If this happens, the infusion will be stopped temporarily and resumed later on at a lower infusion rate.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Possible side effects Electrolyte concentrations Like all medicines, B. Such side effects amioplasmal not specifically related to the solution B. Uncommon side effects affects 1 to 10 treated patients of 1, Headache, shivering, fever If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Aminoplasal product comes in colourless glass bottles of ml, ml and Keep out of the reach and sight of children.


Do not use B. The ml the bottle and carton labels.

Aminoplasmal 10%

The expiry date refers to the last day of that month. Not all pack sizes may be marketed. Keep bottles in the outer carton in order to protect from light. Do not Marketing Authorisation Holder and Manufacturer freeze.

After infusion, any remaining solution should never be stored for later use. This medicinal product is authorised in the Member States of Per litre ml this medicine contains: Special precaution for storage Instructions for handling Use a sterile giving set for infusion of B.

If in the setting of complete 110 nutrition it is necessary to add other nutrients such as carbohydrates, lipids, vitamins and trace elements to this medicinal product, admixing must be performed under aminoplasmap aseptic conditions. Mix well after admixture of any additive. Pay special attention to compatibility. The product must not be used if the solution is not clear or the container or its closure are damaged.

Shake container gently to ensure homogeneity. Storage after mixing with other components From the microbiological point of view, mixtures should be administered immediately after preparation. Latest Drug Information Updates. Ultomiris Ultomiris ravulizumab-cwvz is a long-acting C5 complement inhibitor for the treatment of paroxysmal Xospata Xospata gilteritinib is a kinase inhibitor indicated for the treatment of patients who have relapsed or Daurismo Daurismo glasdegib is a hedgehog pathway inhibitor indicated for the combination treatment of adult Vitrakvi Vitrakvi larotrectinib is an oral selective tropomyosin receptor kinase TRK inhibitor for the treatment